Current Location: HOME >> About Us
Contact Supplier
| Progress Life Sciences Pvt Ltd | |
|---|---|
| Country: | India |
| Tel: | +91-2249781414 |
| Mobile: | +91-22-49781414 |
| E-mail: | info@progresslifesciences.com |
| WhatsApp: | Chat Now! |
| Skype: | Chat Now! |
Pushing the boundaries of Science & Technology to deliver cost effective life science products.
While we continue to thrive on Research & Innovation as our fundamental base to enter into the next phase of our growth, we also look to focus on strategic collaborations & leveraging our global customer base to bring sales growth & improved profatibility.
Established 2016HO in Vashi, Mumbai. Manufacturing unit in Pune Maharashtra. Operating in 5 verticals – Active Pharmaceutical Ingredients (APIs), Intermediates & Spec. Chemicals, Finished Dosage Formulations.
Complex ChemSuccessfully demonstrated the ability to handle complex & haz. Chemistries. Multi step synthesis identified as important differentiator for growth.
Global PlayerServing global customers. Exporting to more than 25 countries. Strong position in Oxicam Series (Lornoxicam, Meloxicam, Piroxicam, Piroxicam BCD, Tenoxicam) & Bromhexine. More than 60% revenue from Exports. 250+ customers.
Research DrivenInnovation based approach to be the best in segment. Backward integrated API & FDF as growth drivers. Flow chemistry and micro reactors for new innovations.
CertificationsISO 9001, 140001, 18001, Halal certified. FDA & GMP for API mfg. Planning to obtain WHO GMP by 2024.
Competent TeamPromoters are from ICT (Formerly known as UDCT). Competent and experienced leadership team to steer growth
While we continue to thrive on Research & Innovation as our fundamental base to enter into the next phase of our growth, we also look to focus on strategic collaborations & leveraging our global customer base to bring sales growth & improved profatibility.
Established 2016HO in Vashi, Mumbai. Manufacturing unit in Pune Maharashtra. Operating in 5 verticals – Active Pharmaceutical Ingredients (APIs), Intermediates & Spec. Chemicals, Finished Dosage Formulations.
Complex ChemSuccessfully demonstrated the ability to handle complex & haz. Chemistries. Multi step synthesis identified as important differentiator for growth.
Global PlayerServing global customers. Exporting to more than 25 countries. Strong position in Oxicam Series (Lornoxicam, Meloxicam, Piroxicam, Piroxicam BCD, Tenoxicam) & Bromhexine. More than 60% revenue from Exports. 250+ customers.
Research DrivenInnovation based approach to be the best in segment. Backward integrated API & FDF as growth drivers. Flow chemistry and micro reactors for new innovations.
CertificationsISO 9001, 140001, 18001, Halal certified. FDA & GMP for API mfg. Planning to obtain WHO GMP by 2024.
Competent TeamPromoters are from ICT (Formerly known as UDCT). Competent and experienced leadership team to steer growth